Business Insurance: Big comp claims raise concerns (subscription required)
Costly catastrophic claims are emerging in the workers compensation sector, partly driven by comorbidities and prescribing of expensive brand-name drugs, experts say.
Costly catastrophic claims are emerging in the workers compensation sector, partly driven by comorbidities and prescribing of expensive brand-name drugs, experts say.
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the services Genex provides.
The AASCIF Annual Conference brings together state funds from across the co
In this recent WC Magazine article, Laney Bond offers a framework to help facilitate improved results from the workers' compensation perspective.
The FDA recently approved a new opioid prodrug, Apadaz (benzhydrocodone and acetaminophen). The oral tablets are designed for short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.